Brian Reemtsen
Concepts (234)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 10 | 2017 | 298 | 2.360 |
Why?
| Extracellular Matrix | 3 | 2017 | 111 | 1.610 |
Why?
| Heart Defects, Congenital | 12 | 2020 | 592 | 1.480 |
Why?
| Heart Ventricles | 7 | 2020 | 248 | 1.330 |
Why?
| Postoperative Complications | 6 | 2019 | 1000 | 0.790 |
Why?
| Anticoagulants | 3 | 2018 | 254 | 0.690 |
Why?
| Heparin | 2 | 2018 | 92 | 0.670 |
Why?
| Ebstein Anomaly | 3 | 2008 | 7 | 0.670 |
Why?
| Vascular Grafting | 1 | 2018 | 7 | 0.620 |
Why?
| Blalock-Taussig Procedure | 1 | 2018 | 17 | 0.610 |
Why?
| Blood Vessel Prosthesis | 2 | 2018 | 85 | 0.600 |
Why?
| Infant | 16 | 2020 | 3551 | 0.580 |
Why?
| Mitral Valve Insufficiency | 1 | 2017 | 44 | 0.570 |
Why?
| Heart Valve Prosthesis Implantation | 4 | 2018 | 80 | 0.560 |
Why?
| Funnel Chest | 2 | 2008 | 10 | 0.530 |
Why?
| Foreign-Body Reaction | 1 | 2015 | 9 | 0.530 |
Why?
| Heart Septum | 1 | 2015 | 23 | 0.520 |
Why?
| Heart Valves | 1 | 2015 | 23 | 0.510 |
Why?
| Calcinosis | 1 | 2015 | 49 | 0.510 |
Why?
| Intestinal Mucosa | 1 | 2015 | 225 | 0.470 |
Why?
| Tetralogy of Fallot | 3 | 2020 | 86 | 0.460 |
Why?
| Cardiopulmonary Bypass | 5 | 2015 | 91 | 0.430 |
Why?
| Prosthesis Implantation | 2 | 2014 | 44 | 0.420 |
Why?
| Treatment Outcome | 14 | 2018 | 5138 | 0.390 |
Why?
| Inflammation | 1 | 2015 | 604 | 0.380 |
Why?
| Male | 28 | 2024 | 25093 | 0.360 |
Why?
| Retrospective Studies | 13 | 2020 | 6117 | 0.360 |
Why?
| Child, Preschool | 13 | 2019 | 3853 | 0.360 |
Why?
| Female | 24 | 2024 | 26329 | 0.350 |
Why?
| Survival Rate | 5 | 2019 | 905 | 0.330 |
Why?
| Cor Triatriatum | 1 | 2008 | 3 | 0.330 |
Why?
| Peptide Fragments | 3 | 2015 | 216 | 0.320 |
Why?
| Vena Cava, Inferior | 2 | 2008 | 79 | 0.320 |
Why?
| Heart Septal Defects, Atrial | 1 | 2008 | 44 | 0.320 |
Why?
| Pulmonary Valve | 3 | 2018 | 46 | 0.320 |
Why?
| Cardiac Catheterization | 4 | 2018 | 196 | 0.310 |
Why?
| Humans | 34 | 2024 | 49827 | 0.300 |
Why?
| Transcriptome | 3 | 2020 | 313 | 0.300 |
Why?
| Infant, Newborn | 7 | 2019 | 2744 | 0.290 |
Why?
| Follow-Up Studies | 5 | 2017 | 2179 | 0.280 |
Why?
| Heart Transplantation | 4 | 2017 | 312 | 0.270 |
Why?
| Palliative Care | 2 | 2010 | 187 | 0.270 |
Why?
| Los Angeles | 5 | 2017 | 30 | 0.260 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 97 | 0.260 |
Why?
| Adolescent | 11 | 2018 | 6340 | 0.240 |
Why?
| Heart | 2 | 2017 | 326 | 0.240 |
Why?
| Child | 12 | 2020 | 6824 | 0.240 |
Why?
| Tricuspid Valve Insufficiency | 2 | 2018 | 14 | 0.240 |
Why?
| Echocardiography | 2 | 2017 | 378 | 0.240 |
Why?
| Heart-Assist Devices | 2 | 2017 | 147 | 0.230 |
Why?
| Coronary Vessel Anomalies | 1 | 2024 | 37 | 0.220 |
Why?
| Sternum | 1 | 2002 | 9 | 0.220 |
Why?
| Thrombosis | 2 | 2017 | 249 | 0.210 |
Why?
| Magnetic Resonance Imaging | 3 | 2017 | 1533 | 0.190 |
Why?
| Reoperation | 2 | 2017 | 452 | 0.190 |
Why?
| Wnt Proteins | 2 | 2019 | 100 | 0.190 |
Why?
| Heart Valve Prosthesis | 2 | 2018 | 75 | 0.180 |
Why?
| DiGeorge Syndrome | 1 | 2020 | 20 | 0.180 |
Why?
| Time Factors | 5 | 2017 | 2912 | 0.170 |
Why?
| Polytetrafluoroethylene | 2 | 2018 | 32 | 0.170 |
Why?
| Graft Survival | 3 | 2017 | 152 | 0.170 |
Why?
| Perfusion | 1 | 2019 | 47 | 0.170 |
Why?
| Immune System | 1 | 1999 | 44 | 0.170 |
Why?
| Thymus Gland | 1 | 1999 | 42 | 0.170 |
Why?
| Cardiac Valve Annuloplasty | 1 | 2018 | 2 | 0.170 |
Why?
| Immune Tolerance | 1 | 1999 | 95 | 0.160 |
Why?
| Tricuspid Valve | 1 | 2018 | 21 | 0.160 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1031 | 0.160 |
Why?
| Norwood Procedures | 1 | 2019 | 56 | 0.160 |
Why?
| Contrast Media | 2 | 2017 | 183 | 0.160 |
Why?
| Pulmonary Valve Insufficiency | 1 | 2018 | 19 | 0.160 |
Why?
| Cerebrovascular Circulation | 1 | 2019 | 131 | 0.160 |
Why?
| Tachycardia, Ventricular | 1 | 2018 | 43 | 0.150 |
Why?
| Hemorrhage | 2 | 2017 | 202 | 0.150 |
Why?
| Transplants | 1 | 2018 | 19 | 0.150 |
Why?
| Critical Illness | 1 | 2020 | 286 | 0.150 |
Why?
| Heart Septal Defects | 1 | 2017 | 11 | 0.150 |
Why?
| Hirudins | 2 | 2014 | 16 | 0.150 |
Why?
| Cell Proliferation | 2 | 2020 | 1007 | 0.140 |
Why?
| California | 1 | 2017 | 87 | 0.140 |
Why?
| Endocarditis | 1 | 2017 | 32 | 0.140 |
Why?
| Physicians | 1 | 2020 | 234 | 0.140 |
Why?
| Off-Label Use | 1 | 2016 | 25 | 0.140 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2017 | 105 | 0.140 |
Why?
| Fibroblast Growth Factors | 1 | 2015 | 47 | 0.130 |
Why?
| Necrosis | 1 | 2015 | 177 | 0.130 |
Why?
| Myocardium | 2 | 2016 | 429 | 0.120 |
Why?
| Fibrosis | 1 | 2015 | 178 | 0.120 |
Why?
| Heart, Artificial | 1 | 2014 | 3 | 0.120 |
Why?
| Premedication | 1 | 2014 | 21 | 0.120 |
Why?
| Graft Rejection | 2 | 2008 | 159 | 0.120 |
Why?
| Animals, Newborn | 3 | 2020 | 366 | 0.110 |
Why?
| Databases, Factual | 1 | 2015 | 664 | 0.100 |
Why?
| Acute Kidney Injury | 1 | 2015 | 283 | 0.100 |
Why?
| Heart Failure | 1 | 2017 | 454 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2018 | 942 | 0.100 |
Why?
| Echocardiography, Transesophageal | 2 | 2008 | 60 | 0.100 |
Why?
| Risk Factors | 5 | 2019 | 3619 | 0.090 |
Why?
| Thrombocytopenia | 1 | 2011 | 84 | 0.090 |
Why?
| Isoantibodies | 2 | 2001 | 27 | 0.090 |
Why?
| Pulmonary Circulation | 2 | 2007 | 34 | 0.090 |
Why?
| Anastomosis, Surgical | 2 | 2007 | 68 | 0.090 |
Why?
| Tachycardia, Supraventricular | 1 | 2010 | 40 | 0.090 |
Why?
| Risk Assessment | 3 | 2010 | 1262 | 0.090 |
Why?
| Epithelial-Mesenchymal Transition | 2 | 2020 | 47 | 0.090 |
Why?
| Fontan Procedure | 1 | 2010 | 63 | 0.090 |
Why?
| Adult | 8 | 2018 | 13160 | 0.080 |
Why?
| Coronary Angiography | 2 | 2024 | 336 | 0.080 |
Why?
| Failure to Thrive | 1 | 2008 | 18 | 0.080 |
Why?
| Catheter Ablation | 1 | 2010 | 121 | 0.080 |
Why?
| Mice, Inbred C57BL | 3 | 2020 | 1806 | 0.080 |
Why?
| Thoracoscopy | 1 | 2008 | 17 | 0.080 |
Why?
| Venous Pressure | 1 | 2008 | 22 | 0.080 |
Why?
| Coronary Thrombosis | 1 | 2008 | 23 | 0.080 |
Why?
| Coronary Aneurysm | 1 | 2008 | 17 | 0.080 |
Why?
| Signal Transduction | 3 | 2020 | 1617 | 0.080 |
Why?
| Constriction, Pathologic | 1 | 2008 | 94 | 0.080 |
Why?
| Pneumothorax | 1 | 2008 | 21 | 0.080 |
Why?
| Pericardium | 1 | 2008 | 29 | 0.080 |
Why?
| Respiratory Paralysis | 1 | 2007 | 6 | 0.080 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2008 | 23 | 0.080 |
Why?
| Phlebography | 1 | 2008 | 62 | 0.080 |
Why?
| Bronchoscopy | 1 | 2008 | 71 | 0.080 |
Why?
| Lung Transplantation | 1 | 2008 | 37 | 0.080 |
Why?
| Biopsy, Needle | 1 | 2008 | 183 | 0.080 |
Why?
| Cohort Studies | 3 | 2019 | 1422 | 0.080 |
Why?
| Diaphragm | 1 | 2007 | 29 | 0.080 |
Why?
| Prosthesis Failure | 1 | 2008 | 107 | 0.070 |
Why?
| Device Removal | 1 | 2008 | 85 | 0.070 |
Why?
| Gene Regulatory Networks | 2 | 2019 | 107 | 0.070 |
Why?
| Hypotension | 1 | 2008 | 63 | 0.070 |
Why?
| Bioprosthesis | 2 | 2018 | 35 | 0.070 |
Why?
| Organ Size | 1 | 2007 | 226 | 0.070 |
Why?
| Blood Circulation | 1 | 2007 | 15 | 0.070 |
Why?
| Scimitar Syndrome | 1 | 2007 | 6 | 0.070 |
Why?
| Abnormalities, Multiple | 1 | 2008 | 167 | 0.070 |
Why?
| Heart Atria | 1 | 2007 | 55 | 0.070 |
Why?
| Pulmonary Veins | 1 | 2007 | 31 | 0.070 |
Why?
| Infant, Low Birth Weight | 1 | 2007 | 62 | 0.070 |
Why?
| Ventricular Dysfunction, Right | 1 | 2007 | 27 | 0.070 |
Why?
| Prosthesis Design | 2 | 2018 | 236 | 0.070 |
Why?
| Young Adult | 4 | 2018 | 3936 | 0.070 |
Why?
| Vascular Surgical Procedures | 1 | 2008 | 168 | 0.070 |
Why?
| Ultrasonography | 1 | 2007 | 436 | 0.070 |
Why?
| Pulmonary Artery | 1 | 2007 | 145 | 0.070 |
Why?
| Incidence | 2 | 2019 | 1003 | 0.060 |
Why?
| Transplantation, Homologous | 2 | 2008 | 138 | 0.060 |
Why?
| Proportional Hazards Models | 2 | 2018 | 406 | 0.060 |
Why?
| Animals | 5 | 2020 | 13150 | 0.060 |
Why?
| Infant, Premature | 1 | 2007 | 308 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2017 | 904 | 0.060 |
Why?
| Recovery of Function | 2 | 2018 | 189 | 0.060 |
Why?
| Aorta, Thoracic | 1 | 2024 | 92 | 0.060 |
Why?
| Hospital Mortality | 2 | 2019 | 413 | 0.050 |
Why?
| Traction | 1 | 2002 | 7 | 0.050 |
Why?
| Middle Aged | 4 | 2018 | 11997 | 0.050 |
Why?
| Prognosis | 2 | 2018 | 1952 | 0.050 |
Why?
| Prospective Studies | 2 | 2019 | 2344 | 0.050 |
Why?
| Orthopedic Procedures | 1 | 2002 | 69 | 0.050 |
Why?
| Histocompatibility Antigens | 1 | 2001 | 6 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2014 | 486 | 0.050 |
Why?
| Equipment Design | 2 | 2013 | 282 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2001 | 182 | 0.050 |
Why?
| Gastrostomy | 1 | 2020 | 55 | 0.040 |
Why?
| E2F1 Transcription Factor | 1 | 2019 | 5 | 0.040 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2019 | 33 | 0.040 |
Why?
| Transplantation Immunology | 1 | 1999 | 6 | 0.040 |
Why?
| Tracheostomy | 1 | 2020 | 75 | 0.040 |
Why?
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2019 | 3 | 0.040 |
Why?
| Genome | 1 | 2019 | 67 | 0.040 |
Why?
| Th2 Cells | 1 | 1999 | 21 | 0.040 |
Why?
| Rats, Inbred Strains | 1 | 1999 | 196 | 0.040 |
Why?
| Antibody Formation | 1 | 1999 | 56 | 0.040 |
Why?
| Th1 Cells | 1 | 1999 | 51 | 0.040 |
Why?
| Mice | 2 | 2020 | 5720 | 0.040 |
Why?
| Poisson Distribution | 1 | 2018 | 34 | 0.040 |
Why?
| Critical Care | 1 | 2020 | 201 | 0.040 |
Why?
| Retinoblastoma Protein | 1 | 2017 | 20 | 0.040 |
Why?
| Echocardiography, Doppler | 1 | 2018 | 52 | 0.040 |
Why?
| Genes, cdc | 1 | 2017 | 6 | 0.040 |
Why?
| Chronic Disease | 2 | 2015 | 563 | 0.040 |
Why?
| Kinetics | 1 | 1999 | 626 | 0.040 |
Why?
| Propensity Score | 1 | 2018 | 124 | 0.040 |
Why?
| Hemodynamics | 1 | 2018 | 229 | 0.040 |
Why?
| Autopsy | 1 | 2017 | 46 | 0.040 |
Why?
| Delivery of Health Care | 1 | 2020 | 307 | 0.040 |
Why?
| Echocardiography, Doppler, Color | 1 | 2016 | 23 | 0.040 |
Why?
| Myoblasts, Cardiac | 1 | 2016 | 2 | 0.040 |
Why?
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2016 | 2 | 0.040 |
Why?
| Observer Variation | 1 | 2017 | 129 | 0.040 |
Why?
| Multivariate Analysis | 1 | 2018 | 585 | 0.030 |
Why?
| Rats | 2 | 2001 | 3300 | 0.030 |
Why?
| Age Distribution | 1 | 2016 | 170 | 0.030 |
Why?
| Down-Regulation | 1 | 2017 | 349 | 0.030 |
Why?
| Cytokines | 1 | 1999 | 612 | 0.030 |
Why?
| Phosphorylation | 1 | 2017 | 536 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2016 | 138 | 0.030 |
Why?
| Patient Safety | 1 | 2016 | 101 | 0.030 |
Why?
| Gene Expression | 1 | 2017 | 608 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2020 | 1541 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2019 | 979 | 0.030 |
Why?
| Antithrombins | 1 | 2014 | 19 | 0.030 |
Why?
| Hyperbilirubinemia | 1 | 2013 | 9 | 0.030 |
Why?
| Compassionate Use Trials | 1 | 2013 | 5 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2017 | 1188 | 0.030 |
Why?
| Body Size | 1 | 2013 | 27 | 0.030 |
Why?
| Multiple Organ Failure | 1 | 2013 | 47 | 0.030 |
Why?
| Waiting Lists | 1 | 2013 | 50 | 0.030 |
Why?
| RNA, Messenger | 1 | 2016 | 1105 | 0.030 |
Why?
| Cells, Cultured | 1 | 2016 | 1571 | 0.030 |
Why?
| Mortality | 1 | 2013 | 99 | 0.030 |
Why?
| Immunohistochemistry | 2 | 2008 | 971 | 0.030 |
Why?
| Liver Diseases | 1 | 2013 | 76 | 0.030 |
Why?
| Cause of Death | 1 | 2013 | 145 | 0.030 |
Why?
| Risk | 1 | 2013 | 320 | 0.030 |
Why?
| Comorbidity | 1 | 2013 | 618 | 0.020 |
Why?
| Kidney Diseases | 1 | 2013 | 214 | 0.020 |
Why?
| Heart Diseases | 1 | 2013 | 208 | 0.020 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 287 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3125 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 651 | 0.020 |
Why?
| United States | 1 | 2019 | 4838 | 0.020 |
Why?
| Phrenic Nerve | 1 | 2007 | 6 | 0.020 |
Why?
| Stroke | 1 | 2013 | 492 | 0.020 |
Why?
| Monitoring, Physiologic | 1 | 2008 | 121 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 854 | 0.020 |
Why?
| Aged | 1 | 2016 | 9272 | 0.010 |
Why?
| Rats, Inbred WF | 1 | 2001 | 2 | 0.010 |
Why?
| Rats, Inbred ACI | 1 | 2001 | 2 | 0.010 |
Why?
| Cyclosporine | 1 | 2001 | 64 | 0.010 |
Why?
| Immunoglobulin G | 1 | 2001 | 186 | 0.010 |
Why?
| Muscle, Smooth, Vascular | 1 | 2001 | 131 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2001 | 587 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2001 | 797 | 0.010 |
Why?
|
|
Reemtsen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|